PARIS, Ky., Dec. 10, 2019 (GLOBE NEWSWIRE) — AgTech Scientific owns and operates a 2,000,000 sq. ft. state-of-the-art greenhouse and ag-processing center in Paris, Kentucky. The company propagated and planted over 7,000,000 clones on over 1,800 acres with local farmers in 2019. The company successfully harvested over 2,700,000 pounds of high-grade extraction-ready biomass. AgTech designed and built its own industrial scale drying, stripping and milling technology to support the 2019 Harvest.Recently, the USDA proposed new regulations to govern the hemp industry. The AgTech Farming First program and ag-processing model is well poised to adapt to the new regulations. Further, AgTech Scientific has been working on ground-breaking clinical research with leading universities since 2017 in the areas of dosing, efficacy and delivery methods.About AgTech ScientificHeadquartered in Paris, Kentucky, AgTech Scientific is a large-scale food supplement provider and product manufacturer with hemp derived compounds as its key ingredients for sale in bulk and in its proprietary consumer packaged goods. AgTech Scientific is dedicated to compliance and controlling every channel within its supply chain to ensure full chain of custody for its R2S (Root to Shelf™) brand of products. The company has two large facilities in Paris, Kentucky within close proximity to each other. The 2,000,000 million sq. ft. greenhouse and ag-processing center allows for year-round indoor cultivation and serves outdoor farming operations in Central Kentucky.The purpose built 50,000 sq. ft. extraction and manufacturing center (phase 2 completion expected in Q1, 2020) has been designed and constructed to meet GMP and ISO standards, producing a variety of bulk T Free formulates and consumer products to mass market scale.The AgTech family includes partners and subsidiaries in 13 states for additional indoor/outdoor growing, extraction, consumer packaged goods manufacturing and distribution.In 2017, the company signed agreements with leading U.S. universities to research AgTech’s hemp derived formulates for safety, dosing, efficacy and delivery methods through quantitative and qualitative clinical studies. The first publication date is anticipated by mid-2020.Watch the following video on AgTech Scientific’s 2019 Harvest here:https://www.youtube.com/watch?v=fbI8RonupO8&t=2sTo learn more about AgTech Scientific and see additional content, visit our website at http://www.agtechscientific.com/ or contact corporate communications at:Jessica Scott
Director of Corporate Communications
Certain statements herein relating to the Company constitute “forward-looking statements” within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward-looking statements.” Such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and/or sales of hemp derived products, quantities of future hemp products production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and/or expansion of production facilities, and other information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in hemp products prices, actual operating performance of facilities, and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Contents are provided for general information purposes only and do not constitute an offer to sell or a solicitation of an offer to buy any security in any jurisdiction. The information in this news release is qualified in its entirety.